Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 5
2014 4
2015 6
2016 4
2017 7
2018 4
2019 4
2020 3
2021 4
2022 4
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma.
Palumbo A, Chanan-Khan A, Weisel K, Nooka AK, Masszi T, Beksac M, Spicka I, Hungria V, Munder M, Mateos MV, Mark TM, Qi M, Schecter J, Amin H, Qin X, Deraedt W, Ahmadi T, Spencer A, Sonneveld P; CASTOR Investigators. Palumbo A, et al. Among authors: mark tm. N Engl J Med. 2016 Aug 25;375(8):754-66. doi: 10.1056/NEJMoa1606038. N Engl J Med. 2016. PMID: 27557302 Free article. Clinical Trial.
Overall Survival With Daratumumab, Bortezomib, and Dexamethasone in Previously Treated Multiple Myeloma (CASTOR): A Randomized, Open-Label, Phase III Trial.
Sonneveld P, Chanan-Khan A, Weisel K, Nooka AK, Masszi T, Beksac M, Spicka I, Hungria V, Munder M, Mateos MV, Mark TM, Levin MD, Ahmadi T, Qin X, Garvin Mayo W, Gai X, Carey J, Carson R, Spencer A. Sonneveld P, et al. Among authors: mark tm. J Clin Oncol. 2023 Mar 10;41(8):1600-1609. doi: 10.1200/JCO.21.02734. Epub 2022 Nov 22. J Clin Oncol. 2023. PMID: 36413710 Free PMC article. Clinical Trial.
Novel Induction Regimens in Multiple Myeloma.
Runcie KD, Mark TM. Runcie KD, et al. Among authors: mark tm. Curr Hematol Malig Rep. 2015 Dec;10(4):388-94. doi: 10.1007/s11899-015-0282-1. Curr Hematol Malig Rep. 2015. PMID: 26275667 Review.
Management of double-refractory multiple myeloma.
Meadows JP, Mark TM. Meadows JP, et al. Among authors: mark tm. Curr Hematol Malig Rep. 2013 Dec;8(4):253-60. doi: 10.1007/s11899-013-0173-2. Curr Hematol Malig Rep. 2013. PMID: 23975677 Review.
Controversies in multiple myeloma: to transplant or not?
Preeshagul IR, Van Besien K, Mark TM. Preeshagul IR, et al. Among authors: mark tm. Curr Hematol Malig Rep. 2014 Dec;9(4):360-7. doi: 10.1007/s11899-014-0230-5. Curr Hematol Malig Rep. 2014. PMID: 25145553 Review.
44 results